Previous Article | Next Article 
Journal of Virology, August 2000, p. 6734-6740, Vol. 74, No. 15
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Human Immunodeficiency Virus Type 1 Virion
Density Is Not Determined by Nucleocapsid Basic Residues
Andrea
Cimarelli and
Jeremy
Luban*
Departments of Microbiology and Medicine,
College of Physicians and Surgeons, Columbia University, New York,
New York 10032
Received 18 February 2000/Accepted 8 May 2000
The human immunodeficiency virus type 1 (HIV-1) Gag polyprotein is
sufficient for assembly and release of virion-like particles from the
plasma membrane. To promote assembly, the Gag polyprotein must
polymerize to form a shell that lines the inner membrane of nascent
virions. Several techniques have been used to functionally map the
domain required for Gag polymerization (the I domain). Among these
methods, isopycnic centrifugation has been used under the assumption
that changes in virion density reflect impairment in Gag-Gag
interaction. If virion density is determined by efficient Gag-Gag
interaction, then mutation of basic residues in the nucleocapsid (NC)
domain should disrupt virion density, since these residues constitute
the I domain. However, we have previously shown that simultaneous
disruption of up to 10 HIV-1 NC basic residues has no obvious effect on
virion density. To rule out the possibility that HIV-1 NC basic
residues other than those previously mutated might be important for
virion density, mutations were introduced at the remaining sites and
the ability of these mutations to affect Gag-Gag interaction and virion
density was analyzed. Included in our analysis is a mutant in which all
NC basic residues are replaced with alanine. Our results show that
disruption of HIV-1 NC basic residues has an enormous effect on Gag-Gag
interaction but only a minimal effect on the density of those virions
that are still produced. Therefore, the determinants of the I domain and of virion density are genetically distinguishable.
*
Corresponding author. Mailing address: Departments of
Microbiology and Medicine, Columbia University, College of Physicians and Surgeons, 701 West 168th St., New York, NY 10032. Phone: (212) 305-8706. Fax: (212) 305-0333. E-mail: JL45{at}columbia.edu.
Journal of Virology, August 2000, p. 6734-6740, Vol. 74, No. 15
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ott, D. E., Coren, L. V., Shatzer, T.
(2009). The Nucleocapsid Region of Human Immunodeficiency Virus Type 1 Gag Assists in the Coordination of Assembly and Gag Processing: Role for RNA-Gag Binding in the Early Stages of Assembly. J. Virol.
83: 7718-7727
[Abstract]
[Full Text]
-
Hogue, I. B., Hoppe, A., Ono, A.
(2009). Quantitative Fluorescence Resonance Energy Transfer Microscopy Analysis of the Human Immunodeficiency Virus Type 1 Gag-Gag Interaction: Relative Contributions of the CA and NC Domains and Membrane Binding. J. Virol.
83: 7322-7336
[Abstract]
[Full Text]
-
Ott, D. E., Coren, L. V., Gagliardi, T. D.
(2005). Redundant Roles for Nucleocapsid and Matrix RNA-Binding Sequences in Human Immunodeficiency Virus Type 1 Assembly. J. Virol.
79: 13839-13847
[Abstract]
[Full Text]
-
Ono, A., Waheed, A. A., Joshi, A., Freed, E. O.
(2005). Association of Human Immunodeficiency Virus Type 1 Gag with Membrane Does Not Require Highly Basic Sequences in the Nucleocapsid: Use of a Novel Gag Multimerization Assay. J. Virol.
79: 14131-14140
[Abstract]
[Full Text]
-
Muriaux, D., Costes, S., Nagashima, K., Mirro, J., Cho, E., Lockett, S., Rein, A.
(2004). Role of Murine Leukemia Virus Nucleocapsid Protein in Virus Assembly. J. Virol.
78: 12378-12385
[Abstract]
[Full Text]
-
Lee, E.-G., Linial, M. L.
(2004). Basic Residues of the Retroviral Nucleocapsid Play Different Roles in Gag-Gag and Gag-{Psi} RNA Interactions. J. Virol.
78: 8486-8495
[Abstract]
[Full Text]
-
Wang, S.-W., Noonan, K., Aldovini, A.
(2004). Nucleocapsid-RNA Interactions Are Essential to Structural Stability but Not to Assembly of Retroviruses. J. Virol.
78: 716-723
[Abstract]
[Full Text]
-
Ott, D. E., Coren, L. V., Chertova, E. N., Gagliardi, T. D., Nagashima, K., Sowder, R. C. II, Poon, D. T. K., Gorelick, R. J.
(2003). Elimination of Protease Activity Restores Efficient Virion Production to a Human Immunodeficiency Virus Type 1 Nucleocapsid Deletion Mutant. J. Virol.
77: 5547-5556
[Abstract]
[Full Text]
-
Berthoux, L., Towers, G. J., Gurer, C., Salomoni, P., Pandolfi, P. P., Luban, J.
(2003). As2O3 Enhances Retroviral Reverse Transcription and Counteracts Ref1 Antiviral Activity. J. Virol.
77: 3167-3180
[Abstract]
[Full Text]
-
Ma, Y. M., Vogt, V. M.
(2002). Rous Sarcoma Virus Gag Protein-Oligonucleotide Interaction Suggests a Critical Role for Protein Dimer Formation in Assembly. J. Virol.
76: 5452-5462
[Abstract]
[Full Text]
-
Demirov, D. G., Ono, A., Orenstein, J. M., Freed, E. O.
(2002). Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. USA
99: 955-960
[Abstract]
[Full Text]
-
Ono, A., Freed, E. O.
(2001). Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. USA
98: 13925-13930
[Abstract]
[Full Text]
-
Cimarelli, A., Luban, J.
(2001). Context-Dependent Phenotype of a Human Immunodeficiency Virus Type 1 Nucleocapsid Mutation. J. Virol.
75: 7193-7197
[Abstract]
[Full Text]
-
Yu, F., Joshi, S. M., Ma, Y. M., Kingston, R. L., Simon, M. N., Vogt, V. M.
(2001). Characterization of Rous Sarcoma Virus Gag Particles Assembled In Vitro. J. Virol.
75: 2753-2764
[Abstract]
[Full Text]